nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—BCHE—Triamcinolone—ankylosing spondylitis	0.18	0.213	CbGbCtD
Chlorpromazine—ABCB11—Dexamethasone—ankylosing spondylitis	0.133	0.157	CbGbCtD
Chlorpromazine—ALB—Prednisone—ankylosing spondylitis	0.0699	0.0825	CbGbCtD
Chlorpromazine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0603	0.0713	CbGbCtD
Chlorpromazine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0451	0.0533	CbGbCtD
Chlorpromazine—ABCB1—Betamethasone—ankylosing spondylitis	0.0392	0.0463	CbGbCtD
Chlorpromazine—ABCB1—Prednisolone—ankylosing spondylitis	0.0387	0.0457	CbGbCtD
Chlorpromazine—ABCB1—Prednisone—ankylosing spondylitis	0.0366	0.0432	CbGbCtD
Chlorpromazine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0362	0.0427	CbGbCtD
Chlorpromazine—ALB—Methotrexate—ankylosing spondylitis	0.0351	0.0414	CbGbCtD
Chlorpromazine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0274	0.0324	CbGbCtD
Chlorpromazine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0235	0.0278	CbGbCtD
Chlorpromazine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0232	0.0274	CbGbCtD
Chlorpromazine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0228	0.027	CbGbCtD
Chlorpromazine—CYP3A4—Prednisone—ankylosing spondylitis	0.0219	0.0259	CbGbCtD
Chlorpromazine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0215	0.0254	CbGbCtD
Chlorpromazine—ABCB1—Methotrexate—ankylosing spondylitis	0.0183	0.0217	CbGbCtD
Chlorpromazine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0137	0.0161	CbGbCtD
Chlorpromazine—Pigmentation skin—Prednisone—ankylosing spondylitis	0.00424	0.0513	CcSEcCtD
Chlorpromazine—Megacolon—Methotrexate—ankylosing spondylitis	0.00395	0.0477	CcSEcCtD
Chlorpromazine—Hypotensive—Betamethasone—ankylosing spondylitis	0.00244	0.0295	CcSEcCtD
Chlorpromazine—Hypotensive—Dexamethasone—ankylosing spondylitis	0.00244	0.0295	CcSEcCtD
Chlorpromazine—Pigmentation disorder—Prednisone—ankylosing spondylitis	0.00232	0.0281	CcSEcCtD
Chlorpromazine—Retinal disorder—Methotrexate—ankylosing spondylitis	0.00181	0.0219	CcSEcCtD
Chlorpromazine—Systemic lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.00177	0.0214	CcSEcCtD
Chlorpromazine—Throat sore—Triamcinolone—ankylosing spondylitis	0.00136	0.0164	CcSEcCtD
Chlorpromazine—Oropharyngeal discomfort—Triamcinolone—ankylosing spondylitis	0.00135	0.0163	CcSEcCtD
Chlorpromazine—Mydriasis—Prednisolone—ankylosing spondylitis	0.00134	0.0162	CcSEcCtD
Chlorpromazine—Sudden death—Methotrexate—ankylosing spondylitis	0.00127	0.0153	CcSEcCtD
Chlorpromazine—Glycosuria—Triamcinolone—ankylosing spondylitis	0.00121	0.0146	CcSEcCtD
Chlorpromazine—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.00121	0.0146	CcSEcCtD
Chlorpromazine—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.00111	0.0135	CcSEcCtD
Chlorpromazine—Glycosuria—Dexamethasone—ankylosing spondylitis	0.0011	0.0133	CcSEcCtD
Chlorpromazine—Glycosuria—Betamethasone—ankylosing spondylitis	0.0011	0.0133	CcSEcCtD
Chlorpromazine—Oropharyngeal pain—Triamcinolone—ankylosing spondylitis	0.00108	0.013	CcSEcCtD
Chlorpromazine—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.00101	0.0122	CcSEcCtD
Chlorpromazine—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.00101	0.0122	CcSEcCtD
Chlorpromazine—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.000969	0.0117	CcSEcCtD
Chlorpromazine—Glycosuria—Prednisone—ankylosing spondylitis	0.000957	0.0116	CcSEcCtD
Chlorpromazine—Endocrine disorder—Prednisone—ankylosing spondylitis	0.000935	0.0113	CcSEcCtD
Chlorpromazine—Amenorrhoea—Prednisone—ankylosing spondylitis	0.000882	0.0107	CcSEcCtD
Chlorpromazine—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.00088	0.0106	CcSEcCtD
Chlorpromazine—Dermatitis contact—Dexamethasone—ankylosing spondylitis	0.00088	0.0106	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.0008	0.00967	CcSEcCtD
Chlorpromazine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.000736	0.0089	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000736	0.00889	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.000734	0.00887	CcSEcCtD
Chlorpromazine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000677	0.00818	CcSEcCtD
Chlorpromazine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000676	0.00816	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000668	0.00807	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000668	0.00807	CcSEcCtD
Chlorpromazine—Influenza—Triamcinolone—ankylosing spondylitis	0.000615	0.00744	CcSEcCtD
Chlorpromazine—Asthma—Triamcinolone—ankylosing spondylitis	0.000615	0.00744	CcSEcCtD
Chlorpromazine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000614	0.00742	CcSEcCtD
Chlorpromazine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000614	0.00742	CcSEcCtD
Chlorpromazine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.000608	0.00735	CcSEcCtD
Chlorpromazine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00058	0.007	CcSEcCtD
Chlorpromazine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000536	0.00647	CcSEcCtD
Chlorpromazine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000535	0.00646	CcSEcCtD
Chlorpromazine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000516	0.00624	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000504	0.00609	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000504	0.00609	CcSEcCtD
Chlorpromazine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.000498	0.00602	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000486	0.00587	CcSEcCtD
Chlorpromazine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000474	0.00572	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000448	0.00541	CcSEcCtD
Chlorpromazine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000439	0.0053	CcSEcCtD
Chlorpromazine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000431	0.0052	CcSEcCtD
Chlorpromazine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000431	0.0052	CcSEcCtD
Chlorpromazine—Angioedema—Prednisolone—ankylosing spondylitis	0.000426	0.00515	CcSEcCtD
Chlorpromazine—Syncope—Prednisolone—ankylosing spondylitis	0.000418	0.00505	CcSEcCtD
Chlorpromazine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00041	0.00495	CcSEcCtD
Chlorpromazine—Asthma—Methotrexate—ankylosing spondylitis	0.000406	0.00491	CcSEcCtD
Chlorpromazine—Convulsion—Prednisolone—ankylosing spondylitis	0.000404	0.00488	CcSEcCtD
Chlorpromazine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000402	0.00486	CcSEcCtD
Chlorpromazine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000392	0.00473	CcSEcCtD
Chlorpromazine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000391	0.00472	CcSEcCtD
Chlorpromazine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000386	0.00466	CcSEcCtD
Chlorpromazine—Syncope—Triamcinolone—ankylosing spondylitis	0.000385	0.00465	CcSEcCtD
Chlorpromazine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000384	0.00464	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000381	0.0046	CcSEcCtD
Chlorpromazine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000377	0.00455	CcSEcCtD
Chlorpromazine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000376	0.00454	CcSEcCtD
Chlorpromazine—Shock—Prednisolone—ankylosing spondylitis	0.000374	0.00452	CcSEcCtD
Chlorpromazine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000374	0.00452	CcSEcCtD
Chlorpromazine—Cough—Triamcinolone—ankylosing spondylitis	0.000374	0.00452	CcSEcCtD
Chlorpromazine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000372	0.00449	CcSEcCtD
Chlorpromazine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000371	0.00449	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000371	0.00448	CcSEcCtD
Chlorpromazine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000371	0.00448	CcSEcCtD
Chlorpromazine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000362	0.00438	CcSEcCtD
Chlorpromazine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000357	0.00431	CcSEcCtD
Chlorpromazine—Angioedema—Betamethasone—ankylosing spondylitis	0.000356	0.0043	CcSEcCtD
Chlorpromazine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000356	0.0043	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00035	0.00423	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000349	0.00422	CcSEcCtD
Chlorpromazine—Syncope—Betamethasone—ankylosing spondylitis	0.000349	0.00422	CcSEcCtD
Chlorpromazine—Syncope—Dexamethasone—ankylosing spondylitis	0.000349	0.00422	CcSEcCtD
Chlorpromazine—Infection—Triamcinolone—ankylosing spondylitis	0.000348	0.0042	CcSEcCtD
Chlorpromazine—Infection—Methylprednisolone—ankylosing spondylitis	0.000347	0.00419	CcSEcCtD
Chlorpromazine—Shock—Triamcinolone—ankylosing spondylitis	0.000344	0.00416	CcSEcCtD
Chlorpromazine—Insomnia—Prednisolone—ankylosing spondylitis	0.000344	0.00416	CcSEcCtD
Chlorpromazine—Shock—Methylprednisolone—ankylosing spondylitis	0.000344	0.00415	CcSEcCtD
Chlorpromazine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000342	0.00413	CcSEcCtD
Chlorpromazine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000342	0.00413	CcSEcCtD
Chlorpromazine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000342	0.00413	CcSEcCtD
Chlorpromazine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000341	0.00412	CcSEcCtD
Chlorpromazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000338	0.00409	CcSEcCtD
Chlorpromazine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000337	0.00407	CcSEcCtD
Chlorpromazine—Convulsion—Betamethasone—ankylosing spondylitis	0.000337	0.00407	CcSEcCtD
Chlorpromazine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000326	0.00394	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000318	0.00384	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000318	0.00384	CcSEcCtD
Chlorpromazine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000317	0.00382	CcSEcCtD
Chlorpromazine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000316	0.00382	CcSEcCtD
Chlorpromazine—Infection—Dexamethasone—ankylosing spondylitis	0.000315	0.00381	CcSEcCtD
Chlorpromazine—Infection—Betamethasone—ankylosing spondylitis	0.000315	0.00381	CcSEcCtD
Chlorpromazine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000313	0.00379	CcSEcCtD
Chlorpromazine—Shock—Dexamethasone—ankylosing spondylitis	0.000312	0.00377	CcSEcCtD
Chlorpromazine—Shock—Betamethasone—ankylosing spondylitis	0.000312	0.00377	CcSEcCtD
Chlorpromazine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000312	0.00377	CcSEcCtD
Chlorpromazine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00031	0.00374	CcSEcCtD
Chlorpromazine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00031	0.00374	CcSEcCtD
Chlorpromazine—Angioedema—Prednisone—ankylosing spondylitis	0.00031	0.00374	CcSEcCtD
Chlorpromazine—Syncope—Prednisone—ankylosing spondylitis	0.000304	0.00367	CcSEcCtD
Chlorpromazine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000298	0.0036	CcSEcCtD
Chlorpromazine—Hypotension—Betamethasone—ankylosing spondylitis	0.000297	0.00359	CcSEcCtD
Chlorpromazine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000297	0.00359	CcSEcCtD
Chlorpromazine—Convulsion—Prednisone—ankylosing spondylitis	0.000294	0.00355	CcSEcCtD
Chlorpromazine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000287	0.00347	CcSEcCtD
Chlorpromazine—Insomnia—Betamethasone—ankylosing spondylitis	0.000287	0.00347	CcSEcCtD
Chlorpromazine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00028	0.00339	CcSEcCtD
Chlorpromazine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000277	0.00334	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000277	0.00334	CcSEcCtD
Chlorpromazine—Infection—Prednisone—ankylosing spondylitis	0.000275	0.00332	CcSEcCtD
Chlorpromazine—Shock—Prednisone—ankylosing spondylitis	0.000272	0.00329	CcSEcCtD
Chlorpromazine—Tachycardia—Prednisone—ankylosing spondylitis	0.00027	0.00326	CcSEcCtD
Chlorpromazine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000258	0.00312	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000257	0.00311	CcSEcCtD
Chlorpromazine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000253	0.00306	CcSEcCtD
Chlorpromazine—Dizziness—Prednisolone—ankylosing spondylitis	0.000252	0.00304	CcSEcCtD
Chlorpromazine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000251	0.00303	CcSEcCtD
Chlorpromazine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000251	0.00303	CcSEcCtD
Chlorpromazine—Insomnia—Prednisone—ankylosing spondylitis	0.00025	0.00302	CcSEcCtD
Chlorpromazine—Cough—Methotrexate—ankylosing spondylitis	0.000247	0.00299	CcSEcCtD
Chlorpromazine—Convulsion—Methotrexate—ankylosing spondylitis	0.000245	0.00296	CcSEcCtD
Chlorpromazine—Constipation—Prednisone—ankylosing spondylitis	0.000236	0.00286	CcSEcCtD
Chlorpromazine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000231	0.0028	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000231	0.00279	CcSEcCtD
Chlorpromazine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000231	0.00279	CcSEcCtD
Chlorpromazine—Infection—Methotrexate—ankylosing spondylitis	0.00023	0.00277	CcSEcCtD
Chlorpromazine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000219	0.00264	CcSEcCtD
Chlorpromazine—Hypotension—Methotrexate—ankylosing spondylitis	0.000216	0.00261	CcSEcCtD
Chlorpromazine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00021	0.00254	CcSEcCtD
Chlorpromazine—Dizziness—Betamethasone—ankylosing spondylitis	0.00021	0.00254	CcSEcCtD
Chlorpromazine—Insomnia—Methotrexate—ankylosing spondylitis	0.000209	0.00253	CcSEcCtD
Chlorpromazine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000206	0.00249	CcSEcCtD
Chlorpromazine—Somnolence—Methotrexate—ankylosing spondylitis	0.000205	0.00248	CcSEcCtD
Chlorpromazine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000204	0.00246	CcSEcCtD
Chlorpromazine—Dizziness—Prednisone—ankylosing spondylitis	0.000183	0.00221	CcSEcCtD
Chlorpromazine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000183	0.00221	CcSEcCtD
Chlorpromazine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00017	0.00206	CcSEcCtD
Chlorpromazine—Dizziness—Methotrexate—ankylosing spondylitis	0.000153	0.00185	CcSEcCtD
Chlorpromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000133	0.00189	CbGpPWpGaD
Chlorpromazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000133	0.00188	CbGpPWpGaD
Chlorpromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000132	0.00186	CbGpPWpGaD
Chlorpromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000131	0.00186	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.00013	0.00184	CbGpPWpGaD
Chlorpromazine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.000129	0.00183	CbGpPWpGaD
Chlorpromazine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.000129	0.00183	CbGpPWpGaD
Chlorpromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000129	0.00183	CbGpPWpGaD
Chlorpromazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000129	0.00182	CbGpPWpGaD
Chlorpromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000128	0.00182	CbGpPWpGaD
Chlorpromazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000128	0.00181	CbGpPWpGaD
Chlorpromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000126	0.00179	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000125	0.00178	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000125	0.00178	CbGpPWpGaD
Chlorpromazine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000123	0.00174	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000123	0.00174	CbGpPWpGaD
Chlorpromazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000122	0.00173	CbGpPWpGaD
Chlorpromazine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000119	0.00168	CbGpPWpGaD
Chlorpromazine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000119	0.00168	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000119	0.00168	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000119	0.00168	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000118	0.00167	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000117	0.00166	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.000117	0.00166	CbGpPWpGaD
Chlorpromazine—DRD5—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000117	0.00165	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.000113	0.0016	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.000113	0.0016	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000112	0.00159	CbGpPWpGaD
Chlorpromazine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000112	0.00158	CbGpPWpGaD
Chlorpromazine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00011	0.00156	CbGpPWpGaD
Chlorpromazine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00011	0.00156	CbGpPWpGaD
Chlorpromazine—KCNH2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.00011	0.00156	CbGpPWpGaD
Chlorpromazine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000108	0.00153	CbGpPWpGaD
Chlorpromazine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000108	0.00153	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000106	0.0015	CbGpPWpGaD
Chlorpromazine—ALB—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000105	0.00148	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000104	0.00147	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000102	0.00145	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000102	0.00144	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000101	0.00144	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000101	0.00143	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.0001	0.00142	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	9.99e-05	0.00142	CbGpPWpGaD
Chlorpromazine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	9.84e-05	0.00139	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling by GPCR—MMP3—ankylosing spondylitis	9.8e-05	0.00139	CbGpPWpGaD
Chlorpromazine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	9.52e-05	0.00135	CbGpPWpGaD
Chlorpromazine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	9.52e-05	0.00135	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—B3GNT2—ankylosing spondylitis	9.49e-05	0.00134	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR ligand binding—PTGER4—ankylosing spondylitis	9.28e-05	0.00132	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—ANTXR2—ankylosing spondylitis	9.07e-05	0.00129	CbGpPWpGaD
Chlorpromazine—HTR6—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.02e-05	0.00128	CbGpPWpGaD
Chlorpromazine—HTR7—GPCR downstream signaling—PTGER4—ankylosing spondylitis	9.01e-05	0.00128	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—ANTXR2—ankylosing spondylitis	8.77e-05	0.00124	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—ANTXR2—ankylosing spondylitis	8.77e-05	0.00124	CbGpPWpGaD
Chlorpromazine—DRD4—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.62e-05	0.00122	CbGpPWpGaD
Chlorpromazine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	8.52e-05	0.00121	CbGpPWpGaD
Chlorpromazine—ALB—Folate Metabolism—TNF—ankylosing spondylitis	8.51e-05	0.00121	CbGpPWpGaD
Chlorpromazine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	8.25e-05	0.00117	CbGpPWpGaD
Chlorpromazine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	8.25e-05	0.00117	CbGpPWpGaD
Chlorpromazine—HTR2B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.23e-05	0.00117	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.19e-05	0.00116	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling by GPCR—PTGER4—ankylosing spondylitis	8.18e-05	0.00116	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—PTGER4—ankylosing spondylitis	8.13e-05	0.00115	CbGpPWpGaD
Chlorpromazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	7.95e-05	0.00113	CbGpPWpGaD
Chlorpromazine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	7.95e-05	0.00113	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL1R2—ankylosing spondylitis	7.85e-05	0.00111	CbGpPWpGaD
Chlorpromazine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	7.85e-05	0.00111	CbGpPWpGaD
Chlorpromazine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	7.85e-05	0.00111	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.83e-05	0.00111	CbGpPWpGaD
Chlorpromazine—DRD1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.76e-05	0.0011	CbGpPWpGaD
Chlorpromazine—DRD3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.66e-05	0.00108	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL1R2—ankylosing spondylitis	7.6e-05	0.00108	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL1R2—ankylosing spondylitis	7.6e-05	0.00108	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling by GPCR—MMP3—ankylosing spondylitis	7.55e-05	0.00107	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.47e-05	0.00106	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—ERAP1—ankylosing spondylitis	7.45e-05	0.00105	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	7.34e-05	0.00104	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—ERAP1—ankylosing spondylitis	7.2e-05	0.00102	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—ERAP1—ankylosing spondylitis	7.2e-05	0.00102	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	7.1e-05	0.00101	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	7.1e-05	0.00101	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	7.05e-05	0.000999	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.05e-05	0.000999	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.95e-05	0.000985	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—B3GNT2—ankylosing spondylitis	6.95e-05	0.000985	CbGpPWpGaD
Chlorpromazine—HTR1A—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	6.9e-05	0.000977	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	6.82e-05	0.000966	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	6.82e-05	0.000966	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CARD9—ankylosing spondylitis	6.81e-05	0.000965	CbGpPWpGaD
Chlorpromazine—ALB—Selenium Micronutrient Network—TNF—ankylosing spondylitis	6.76e-05	0.000958	CbGpPWpGaD
Chlorpromazine—HTR1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.67e-05	0.000946	CbGpPWpGaD
Chlorpromazine—HTR2C—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.64e-05	0.000941	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CARD9—ankylosing spondylitis	6.59e-05	0.000933	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CARD9—ankylosing spondylitis	6.59e-05	0.000933	CbGpPWpGaD
Chlorpromazine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	6.46e-05	0.000915	CbGpPWpGaD
Chlorpromazine—ADRA1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.36e-05	0.0009	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—PTGER4—ankylosing spondylitis	6.27e-05	0.000888	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.06e-05	0.000859	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.03e-05	0.000854	CbGpPWpGaD
Chlorpromazine—HTR2A—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	5.96e-05	0.000844	CbGpPWpGaD
Chlorpromazine—DRD2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.86e-05	0.00083	CbGpPWpGaD
Chlorpromazine—CHRM2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	5.85e-05	0.000829	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling by GPCR—MMP3—ankylosing spondylitis	5.83e-05	0.000826	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling by GPCR—MMP3—ankylosing spondylitis	5.82e-05	0.000825	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—MMP3—ankylosing spondylitis	5.79e-05	0.00082	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—B3GNT2—ankylosing spondylitis	5.79e-05	0.00082	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.77e-05	0.000818	CbGpPWpGaD
Chlorpromazine—HTR2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.77e-05	0.000817	CbGpPWpGaD
Chlorpromazine—HRH1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.75e-05	0.000815	CbGpPWpGaD
Chlorpromazine—CHRM1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.73e-05	0.000812	CbGpPWpGaD
Chlorpromazine—CHRM3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.72e-05	0.00081	CbGpPWpGaD
Chlorpromazine—CHRM2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.66e-05	0.000802	CbGpPWpGaD
Chlorpromazine—ADRA1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.65e-05	0.0008	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling by GPCR—MMP3—ankylosing spondylitis	5.57e-05	0.00079	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	5.38e-05	0.000762	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—B3GNT2—ankylosing spondylitis	5.35e-05	0.000758	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—B3GNT2—ankylosing spondylitis	5.35e-05	0.000757	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—MMP3—ankylosing spondylitis	5.32e-05	0.000754	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.32e-05	0.000754	CbGpPWpGaD
Chlorpromazine—ADRA2A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.25e-05	0.000743	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.24e-05	0.000742	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.22e-05	0.00074	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.21e-05	0.000738	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	5.2e-05	0.000737	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	5.2e-05	0.000737	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.19e-05	0.000735	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—B3GNT2—ankylosing spondylitis	5.17e-05	0.000733	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—B3GNT2—ankylosing spondylitis	5.17e-05	0.000733	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.14e-05	0.000728	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.13e-05	0.000726	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.02e-05	0.000711	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—MMP3—ankylosing spondylitis	4.95e-05	0.000701	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—B3GNT2—ankylosing spondylitis	4.91e-05	0.000695	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—PTGER4—ankylosing spondylitis	4.84e-05	0.000685	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—PTGER4—ankylosing spondylitis	4.83e-05	0.000684	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.76e-05	0.000675	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—PTGER4—ankylosing spondylitis	4.62e-05	0.000655	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	4.51e-05	0.000638	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	4.48e-05	0.000634	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—MMP3—ankylosing spondylitis	4.46e-05	0.000632	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—PTGER4—ankylosing spondylitis	4.41e-05	0.000625	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.38e-05	0.000621	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.35e-05	0.000616	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	4.34e-05	0.000615	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	4.33e-05	0.000614	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	4.33e-05	0.000614	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—MMP3—ankylosing spondylitis	4.32e-05	0.000611	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—MMP3—ankylosing spondylitis	4.29e-05	0.000608	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HLA-C—ankylosing spondylitis	4.28e-05	0.000606	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.24e-05	0.000601	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.24e-05	0.000601	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.2e-05	0.000596	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.2e-05	0.000596	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	4.2e-05	0.000595	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	4.2e-05	0.000595	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.17e-05	0.000591	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.16e-05	0.00059	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HLA-C—ankylosing spondylitis	4.14e-05	0.000586	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HLA-C—ankylosing spondylitis	4.14e-05	0.000586	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—MMP3—ankylosing spondylitis	4.11e-05	0.000582	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—PTGER4—ankylosing spondylitis	4.11e-05	0.000582	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.03e-05	0.000571	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.03e-05	0.000571	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—B3GNT2—ankylosing spondylitis	3.87e-05	0.000549	CbGpPWpGaD
Chlorpromazine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.86e-05	0.000547	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	3.84e-05	0.000544	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.79e-05	0.000537	CbGpPWpGaD
Chlorpromazine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.74e-05	0.000529	CbGpPWpGaD
Chlorpromazine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.74e-05	0.000529	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—MMP3—ankylosing spondylitis	3.73e-05	0.000528	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—MMP3—ankylosing spondylitis	3.72e-05	0.000527	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL1RN—ankylosing spondylitis	3.71e-05	0.000526	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	3.71e-05	0.000526	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	3.71e-05	0.000526	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—MMP3—ankylosing spondylitis	3.71e-05	0.000525	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—MMP3—ankylosing spondylitis	3.7e-05	0.000524	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	3.68e-05	0.000521	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.66e-05	0.000519	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—MMP3—ankylosing spondylitis	3.65e-05	0.000517	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL1RN—ankylosing spondylitis	3.59e-05	0.000509	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL1RN—ankylosing spondylitis	3.59e-05	0.000509	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.58e-05	0.000507	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PTGER4—ankylosing spondylitis	3.56e-05	0.000505	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	3.56e-05	0.000504	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	3.56e-05	0.000504	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—MMP3—ankylosing spondylitis	3.44e-05	0.000488	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—MMP3—ankylosing spondylitis	3.44e-05	0.000487	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PTGER4—ankylosing spondylitis	3.41e-05	0.000483	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.39e-05	0.000481	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—MMP3—ankylosing spondylitis	3.39e-05	0.000481	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—MMP3—ankylosing spondylitis	3.29e-05	0.000467	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CD79A—ankylosing spondylitis	3.26e-05	0.000462	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	3.2e-05	0.000453	CbGpPWpGaD
Chlorpromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.19e-05	0.000452	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CD79A—ankylosing spondylitis	3.15e-05	0.000447	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CD79A—ankylosing spondylitis	3.15e-05	0.000447	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—MMP3—ankylosing spondylitis	3.14e-05	0.000445	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PTGER4—ankylosing spondylitis	3.14e-05	0.000445	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	3.09e-05	0.000438	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.09e-05	0.000438	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.09e-05	0.000437	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.08e-05	0.000436	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PTGER4—ankylosing spondylitis	3.07e-05	0.000434	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PTGER4—ankylosing spondylitis	3.04e-05	0.00043	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.03e-05	0.000429	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	2.99e-05	0.000424	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	2.99e-05	0.000424	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—MMP3—ankylosing spondylitis	2.96e-05	0.00042	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—MMP3—ankylosing spondylitis	2.92e-05	0.000414	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PTGER4—ankylosing spondylitis	2.81e-05	0.000399	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	2.71e-05	0.000384	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL1A—ankylosing spondylitis	2.67e-05	0.000379	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CD40LG—ankylosing spondylitis	2.66e-05	0.000377	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL1A—ankylosing spondylitis	2.59e-05	0.000366	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL1A—ankylosing spondylitis	2.59e-05	0.000366	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CD40LG—ankylosing spondylitis	2.57e-05	0.000364	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CD40LG—ankylosing spondylitis	2.57e-05	0.000364	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	2.57e-05	0.000364	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MMP3—ankylosing spondylitis	2.55e-05	0.000361	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MMP3—ankylosing spondylitis	2.54e-05	0.000359	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HLA-B—ankylosing spondylitis	2.53e-05	0.000358	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.48e-05	0.000352	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	2.48e-05	0.000352	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HLA-B—ankylosing spondylitis	2.45e-05	0.000347	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HLA-B—ankylosing spondylitis	2.45e-05	0.000347	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MMP3—ankylosing spondylitis	2.43e-05	0.000344	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—HLA-A—ankylosing spondylitis	2.34e-05	0.000332	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—HLA-A—ankylosing spondylitis	2.27e-05	0.000321	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—HLA-A—ankylosing spondylitis	2.27e-05	0.000321	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MMP3—ankylosing spondylitis	2.24e-05	0.000317	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—CRP—ankylosing spondylitis	2.24e-05	0.000317	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MMP3—ankylosing spondylitis	2.2e-05	0.000312	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MMP3—ankylosing spondylitis	2.2e-05	0.000311	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MMP3—ankylosing spondylitis	2.19e-05	0.00031	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MMP3—ankylosing spondylitis	2.18e-05	0.000309	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—HLA-A—ankylosing spondylitis	2.16e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MMP3—ankylosing spondylitis	2.16e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—CRP—ankylosing spondylitis	2.16e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—CRP—ankylosing spondylitis	2.16e-05	0.000306	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MMP3—ankylosing spondylitis	2.16e-05	0.000306	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—TLR4—ankylosing spondylitis	2.14e-05	0.000304	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—HLA-A—ankylosing spondylitis	2.09e-05	0.000296	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—HLA-A—ankylosing spondylitis	2.09e-05	0.000296	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.09e-05	0.000296	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—TLR4—ankylosing spondylitis	2.07e-05	0.000294	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—TLR4—ankylosing spondylitis	2.07e-05	0.000294	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP3—ankylosing spondylitis	2e-05	0.000284	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	1.83e-05	0.000259	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	1.77e-05	0.000251	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	1.77e-05	0.000251	CbGpPWpGaD
